{"title":"乳房x光检查。","authors":"J Pontén","doi":"10.1007/BF02987180","DOIUrl":null,"url":null,"abstract":"<p><p>A comparison is made of breast cancer mortality in women included in a mammography screening program, including those who refused to attend, and women who were not included--even those who underwent voluntary mammography. About 215,000 women in five different studies showed between 4 and 24% reduction of mortality; however, this was significant in only two of the studies. No significant reduction was seen in those under 50 yr of age.</p>","PeriodicalId":77257,"journal":{"name":"Medical oncology and tumor pharmacotherapy","volume":"8 3","pages":"203-5"},"PeriodicalIF":0.0000,"publicationDate":"1991-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/BF02987180","citationCount":"0","resultStr":"{\"title\":\"Mammography.\",\"authors\":\"J Pontén\",\"doi\":\"10.1007/BF02987180\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>A comparison is made of breast cancer mortality in women included in a mammography screening program, including those who refused to attend, and women who were not included--even those who underwent voluntary mammography. About 215,000 women in five different studies showed between 4 and 24% reduction of mortality; however, this was significant in only two of the studies. No significant reduction was seen in those under 50 yr of age.</p>\",\"PeriodicalId\":77257,\"journal\":{\"name\":\"Medical oncology and tumor pharmacotherapy\",\"volume\":\"8 3\",\"pages\":\"203-5\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1991-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1007/BF02987180\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Medical oncology and tumor pharmacotherapy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1007/BF02987180\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medical oncology and tumor pharmacotherapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/BF02987180","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
A comparison is made of breast cancer mortality in women included in a mammography screening program, including those who refused to attend, and women who were not included--even those who underwent voluntary mammography. About 215,000 women in five different studies showed between 4 and 24% reduction of mortality; however, this was significant in only two of the studies. No significant reduction was seen in those under 50 yr of age.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
